RT @DrYukselUrun: A post hoc analysis of the phase 3 OAK trial: 🔶Patients with non–small cell lung cancer and a low baseline neutrophil to…
2,322 followers
622 followers
RT @JournalCancer: #OpenAccess | In this analysis, a low baseline NLR identified patients with #NSCLC who derived a greater survival benefi…
29,612 followers
#OpenAccess | In this analysis, a low baseline NLR identified patients with #NSCLC who derived a greater survival benefit from atezolizumab in comparison with those identified in the docetaxel cohort https://t.co/QvU8rXpUia https://t.co/iMAoQM2Nty
2,113 followers
@NicoleKuderer @exosome @NatureComms @JCO_ASCO @DJPinato @ACortelliniMD @M_Tagliamento @matteolambe @Dr_AmerZeidan @DrJFriedberg https://t.co/tG2dgfb7QF. @ACortelliniMD @DJPinato myself and others published recently on post hoc analysis from the phase 3 O